These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2616981)

  • 1. [Monoclonal antibodies. Their usefulness in the diagnosis of malignant tumors of the digestive system].
    Campos Campos F; Romero Navarro MA; Gutiérrez Samperio C; Esquivel P; Gaviño Chapa JF
    Rev Gastroenterol Mex; 1989; 54(4):193-8. PubMed ID: 2616981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of a new serum marker of human digestive cancer: the carbohydrate antigen 19.9; comparison with the carcinoembryonic antigen].
    Olsson NO; Crimet-Montange D; Martin F
    Gastroenterol Clin Biol; 1985 Mar; 9(3):206-11. PubMed ID: 3859449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer].
    Anzai K; Kurihara M; Izumi T
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1437-47. PubMed ID: 2212836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of tumor markers in digestive oncology].
    Ychou M; Rougier P; Bidart JM; Bellet D; Tigaud JM; Bohuon C
    Ann Chir; 1989; 43(7):517-23. PubMed ID: 2694905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum level of tumor markers (antigen Ca 19-9, CEA, ferritin) in digestive tumors. Their diagnostic usefulness].
    Jovin G; Stănel I; Popovici I; Oproiu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(3):223-9. PubMed ID: 2904162
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the measurement of serum carcinoembryonic antigen (CEA) levels using monoclonal antibody].
    Yoneshima M; Sawabu N; Kidani H; Takemori Y; Toya D; Okai T; Hattori N; Ogino T; Mai M
    Gan No Rinsho; 1985 Aug; 31(10):1311-7. PubMed ID: 4057566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of the determination of CA 19-9 in the follow-up of patients with gastroenteric neoplasms in comparison to CEA].
    Pecchio F; Piantino P; Oliaro A; Rapellino M; Ricci E; Aimo G; Obert R
    Minerva Med; 1986 Nov; 77(42-43):1973-81. PubMed ID: 3464850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen fraction in digestive cancer.
    Fong S; García Vega G; León V
    Neoplasma; 1985; 32(2):199-208. PubMed ID: 4000309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of serum TAC-41 in various digestive cancers].
    Sato S; Yamanaka T; Kimura K
    Rinsho Byori; 1989 Nov; 37(11):1259-62. PubMed ID: 2601083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated antigen CA 15-3 in the diagnostics of breast tumours.
    Eskelinen M; Tikanoja S; Valkamo E; Loikkanen M; Collan Y
    Scand J Clin Lab Invest; 1988 Nov; 48(7):653-8. PubMed ID: 3201097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
    Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
    J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood levels of CA-50, CA-19.9, CA-125, enolase, CA-15.3 and carcinoembryonic antigen in non-cancerous bronchopulmonary pathology].
    Berthiot G; Marechal F; Deltour G
    Rev Mal Respir; 1988; 5(6):573-6. PubMed ID: 3217589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT
    Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of colorectal cancer using monoclonal antibodies].
    Inagi H; Okuda H; Shimano T; Kadota T; Mori T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2291-7. PubMed ID: 3460528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characterization and detection of cancer-associated antigens in patients with gastric cancer].
    Yuan M
    Zhonghua Yi Xue Za Zhi; 1993 Aug; 73(8):457-61, 509. PubMed ID: 7509252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of fecal detection of cancer-associated antigens using monoclonal antibodies in the diagnosis of colorectal cancer].
    Yuan M
    Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):497-500, 511-2. PubMed ID: 2086118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
    Huang C; Bei L; Liu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.